Quercetin 用于 高血压
B 证据 至少一项随机试验支持这一结论,结果基本一致。Meta-analysis of 17 RCTs: systolic -3.09 mmHg at >=500 mg/day. More effective in >=8-week studies and hypertensive subjects. Phytosome form preferred for bioavailability.
结论
Meta-analysis of 17 RCTs: systolic -3.09 mmHg at >=500 mg/day. More effective in >=8-week studies and hypertensive subjects. Phytosome form preferred for bioavailability.
Key Study Findings
研究人群: Human dermal follicle papilla cells (in vitro)
研究人群: None
研究人群: AD patients and healthy elderly
研究人群: review of plant-derived anti-inflammatory compounds for chronic disease prevention
研究人群: Allergic rhinitis mouse model
研究人群: Review of flavonoids/phenolics in diabetic macrovascular
Key Statistics
17
研究数量
900
受试者
Positive
等级
Referenced Papers
Dosage & Usage
mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units
常用剂量
- general:
- 500-1,000 mg/day
- bloodpressuresupport:
- 500-730 mg/day
上限: Not formally established; up to 1,000 mg/day used in clinical trials
研究中使用的剂量
| 剂量 | 持续时间 | 效果 | N |
|---|---|---|---|
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
| None | -- | Mixed | -- |
| None | -- | Positive | -- |
| None | -- | Positive | -- |
最佳服用时间: With meals; vitamin C co-supplementation may enhance bioavailability
Safety & Side Effects
已报告的副作用
- ⚠ Generally well-tolerated
- ⚠ Headache (rare)
- ⚠ Mild gastrointestinal discomfort
- ⚠ Tingling in extremities (rare, high doses)
已知相互作用
- ● Antibiotics (quinolones — may reduce efficacy)
- ● Cyclosporine (may increase blood levels)
- ● Anticoagulants (may have mild antiplatelet effect)
- ● Blood pressure medications (additive effect)
可耐受最高摄入量: Not formally established; up to 1,000 mg/day used in clinical trials
在开始服用任何补充剂之前,请务必咨询您的医疗保健提供者。
Frequently Asked Questions
Does Quercetin help with 高血压?
How much Quercetin should I take for 高血压?
Are there side effects of Quercetin?
How strong is the evidence for Quercetin and 高血压?
Related Evidence
其他成分用于 高血压
Quercetin 用于其他健康状况
References
- [1] Kazuhiko Nakadate et al.. Int J Mol Sci. 2025. Anti-Inflammatory Actions of Plant-Derived Compounds and Prevention of Chronic Diseases: From Molecular Mechanisms to Applications. doi:10.3390/ijms26115206 PubMed
- [2] Monika Martiniakova et al.. Nutrients. 2025. Protective Role of Dietary Polyphenols in the Management and Treatment of Type 2 Diabetes Mellitus. doi:10.3390/nu17020275 PubMed
- [3] Matteo Naso et al.. Nutrients. 2025. Quercetin and Its Lecithin-Based Formulation: Potential Applications for Allergic Diseases Based on a Narrative Review. doi:10.3390/nu17091476 PubMed
- [4] Xing-Yuan Li et al.. J Ethnopharmacol. 2025. Inhibition of mitochondrial oxidative stress and apoptosis in the protection of Ginkgo biloba extract 50 against cognitive impairment. doi:10.1016/j.jep.2025.120059 PubMed
- [5] Ki-Yeon Yoo et al.. Biology (Basel). 2025. Therapeutic Potential of Natural Compounds for Brain Ischemia-Reperfusion Injury. doi:10.3390/biology14091153 PubMed
- [6] Sihong Huang et al.. Curr Comput Aided Drug Des. 2025. Exploration of Potential Targets and Molecular Mechanisms of the Yiqi Jianpi Tongqiao Formula in Treating Allergic Rhinitis Mouse Model based … doi:10.2174/0115734099299714240516160158 PubMed
- [7] Feng Gu et al.. Asia Pac J Clin Nutr. 2025. Effects of plant-derived dietary antioxidants on Alzheimer's disease: Focus on ferroptosis. doi:10.6133/apjcn.202512_34(6).0007 PubMed
- [8] Aminu Mohammed et al.. Phytother Res. 2025. The Roles of Flavonoids and Other Plant-Based Phenolics in Mitigating Diabetes-Induced Macrovascular Complications. doi:10.1002/ptr.70070 PubMed
- [9] Adal Mena-García et al.. Molecules. 2025. Kyoh® Rocket Leaf Extract Regulates Proliferation and VEGF and FGF7 Expression in Human Dermal Follicle Papilla Cells. doi:10.3390/molecules30071489 PubMed
- [10] Masoumeh Shamsi et al.. Iran J Pharm Res. 2024. Dual Modulation of Canonical and Non-canonical TGF-β/ROS/Erk1/2 Pathways: Synergistic Activation of Nrf-2 and Antioxidant Enzymes (SOD1, GPx, HO-1) by Quercetin … doi:10.5812/ijpr-151428 PubMed
- [11] Devi Datt Joshi et al.. Indian J Microbiol. 2024. Relevance of Indian Traditional Herbal Brews for Gut Microbiota Balance. doi:10.1007/s12088-024-01251-4 PubMed
- [12] T N Bobrysheva et al.. Vopr Pitan. 2023. [Polyphenols as promising bioactive compounds]. doi:10.33029/0042-8833-2023-92-1-92-107 PubMed
- [13] Sina Kaag et al.. Cells. 2023. Effects of Dietary Components on Mast Cells: Possible Use as Nutraceuticals for Allergies? doi:10.3390/cells12222602 PubMed
- [14] Karen S Coutinho-Wolino et al.. Nutr Res. 2022. Bioactive compounds modulating Toll-like 4 receptor (TLR4)-mediated inflammation: pathways involved and future perspectives. doi:10.1016/j.nutres.2022.09.001 PubMed
- [15] Alzbeta Katonova et al.. Int J Mol Sci. 2022. Effect of a Vegan Diet on Alzheimer's Disease. doi:10.3390/ijms232314924 PubMed
- [16] Minye Qu et al.. Evid Based Complement Alternat Med. 2022. Network Pharmacology and Molecular Docking Study of Yupingfeng Powder in the Treatment of Allergic Diseases. doi:10.1155/2022/1323744 PubMed
- [17] Pamela Senesi et al.. Int J Mol Sci. 2021. Diabetes Mellitus and Cardiovascular Diseases: Nutraceutical Interventions Related to Caloric Restriction. doi:10.3390/ijms22157772 PubMed
- [18] Takayuki Okumo et al.. Medicines (Basel). 2021. Inhibition of Angiogenic Factor Productions by Quercetin In Vitro and In Vivo. doi:10.3390/medicines8050022 PubMed
- [19] Gang Gong et al.. Biomed Pharmacother. 2020. Isorhamnetin: A review of pharmacological effects. doi:10.1016/j.biopha.2020.110301 PubMed
- [20] Wang Anlu et al.. Pharmacol Res. 2019. Using herbal medicine to target the "microbiota-metabolism-immunity" axis as possible therapy for cardiovascular disease. doi:10.1016/j.phrs.2019.02.018 PubMed
- [21] A Tressera-Rimbau et al.. Oxid Med Cell Longev. 2017. Dietary Polyphenols in the Prevention of Stroke. doi:10.1155/2017/7467962 PubMed
- [22] Kevin M Nash et al.. Integr Med Insights. 2015. Current Perspectives on the Beneficial Role of Ginkgo biloba in Neurological and Cerebrovascular Disorders. doi:10.4137/IMI.S25054 PubMed
- [23] Irfan Rahman. Int J Chron Obstruct Pulmon Dis. 2006. Antioxidant therapies in COPD. doi:10.2147/copd.2006.1.1.15 PubMed
- [24] Irfan Rahman et al.. Curr Drug Targets. 2006. Antioxidant therapeutic targets in COPD. doi:10.2174/138945006777435254 PubMed
- [25] Amanpreet Singh et al.. J Med Food. 2002. Effect of natural and synthetic antioxidants in a mouse model of chronic fatigue syndrome. doi:10.1089/109662002763003366 PubMed
- [26] S M Thornhill et al.. Altern Med Rev. 2000. Natural treatment of perennial allergic rhinitis. PubMed
FDA 免责声明: 这些声明未经美国食品药品监督管理局(FDA)评估。本网站上的产品和信息无意用于诊断、治疗、治愈或预防任何疾病。所展示的证据等级基于我们对已发表的同行评审研究的分析,不构成医疗建议。在开始任何补充剂方案之前,请务必咨询您的医疗保健提供者。